These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10900294)

  • 1. Biological variability in assessing the clinical value of biochemical markers of bone turnover.
    Plebani M; Bernardi D; Meneghetti MF; Ujka F; Zaninotto M
    Clin Chim Acta; 2000 Sep; 299(1-2):77-86. PubMed ID: 10900294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary output of hydroxylysine glycosides and pyridinium cross-links in detecting rat bone collagen turnover rate.
    Grazioli V; Alfano M; Stenico A; Casari E
    FEBS Lett; 1996 Jun; 388(2-3):134-8. PubMed ID: 8690072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performances of galactosyl hydroxylysine, pyridinoline, and deoxypyridinoline in postmenopausal osteoporosis.
    Bettica P; Taylor AK; Talbot J; Moro L; Talamini R; Baylink DJ
    J Clin Endocrinol Metab; 1996 Feb; 81(2):542-6. PubMed ID: 8636265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
    Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
    Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in urinary excretion of bone resorption markers: limitations of a single determination in clinical practice.
    Borderie D; Roux C; Toussaint B; Dougados M; Ekindjian OG; Cherruau B
    Clin Biochem; 2001 Oct; 34(7):571-7. PubMed ID: 11738394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galactosylhydroxylysine and pyridinium cross links in monitoring the bone response to hormone replacement therapy.
    Marabini R; Sirtori P; Chionna R; Barzizza L; Rubinacci A
    J Endocrinol Invest; 1996 Mar; 19(3):154-8. PubMed ID: 8743280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared.
    Bettica P; Moro L; Robins SP; Taylor AK; Talbot J; Singer FR; Baylink DJ
    Clin Chem; 1992 Nov; 38(11):2313-8. PubMed ID: 1424129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of analytical performance and biological variability of three bone resorption assays.
    Ju HS; Leung S; Brown B; Stringer MA; Leigh S; Scherrer C; Shepard K; Jenkins D; Knudsen J; Cannon R
    Clin Chem; 1997 Sep; 43(9):1570-6. PubMed ID: 9299935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic method for measuring hydroxylysine glycosides and their ratio in urine as a possible marker of human bone collagen breakdown.
    Grazioli V; Casari E; Murone M; Bonini PA
    J Chromatogr; 1993 May; 615(1):59-66. PubMed ID: 8340463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W; Muley T; Herb KP; Schmidt-Gayk H
    Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical markers of bone turnover for the clinical assessment of bone metabolism.
    Taylor AK; Lueken SA; Libanati C; Baylink DJ
    Rheum Dis Clin North Am; 1994 Aug; 20(3):589-607. PubMed ID: 7984780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study on biochemical markers of bone collagen breakdown in post-menopausal women.
    Sirtori P; Sosio C; Polo RM; Tenni R; Rubinacci A
    Pharmacol Res; 1997 Sep; 36(3):229-35. PubMed ID: 9367668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary galactosyl-hydroxylysine in postmenopausal osteoporotic women: A potential marker of bone fragility.
    Lo Cascio V; Bertoldo F; Gambaro G; Gasperi E; Furlan F; Colapietro F; Lo Cascio C; Campagnola M
    J Bone Miner Res; 1999 Aug; 14(8):1420-4. PubMed ID: 10457275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
    Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
    Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
    Okabe R; Inaba M; Nakatsuka K; Miki T; Naka H; Moriguchi A; Nishizawa Y
    J Bone Miner Metab; 2004; 22(2):127-31. PubMed ID: 14999523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
    Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
    Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
    Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME
    Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failure.
    Coen G; Mantella D; Calabria S; Sardella D; Manni M; Fassino V; D'Anello E; Giustini M; Taggi F
    Am J Nephrol; 2000; 20(4):283-90. PubMed ID: 10970981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary markers of altered collagen metabolism in fibromyalgia patients.
    Ribel-Madsen S; Christgau S; Gronemann ST; Bartels EM; Danneskiold-Samsøe B; Bliddal H
    Scand J Rheumatol; 2007; 36(6):470-7. PubMed ID: 18092271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.